Tags: AS | China | DEA Visit

New DEA Office, Top-level Visit Showcase China Drugs Concern

Friday, 06 Jan 2017 05:55 AM

SHANGHAI (AP) — The U.S. Drug Enforcement Administration is opening a new office in southern China and sending its top administrator to visit next week for the first time in more than a decade, signs of growing U.S. concern about China's role in the global drug trade.

The DEA said acting administrator Chuck Rosenberg will visit Beijing, Guangzhou and Hong Kong Monday through Thursday, at the invitation of China's Ministry of Public Security. The last time the head of the DEA visited the country was 2005. China's National Narcotics Control Commission told AP the invitation had been extended to further strengthen cooperation between the countries.

The new office in the city of Guangzhou will be staffed with two special agents.

DEA and others point to China as the top source country for synthetic opioids like fentanyl and its precursors, which have been fueling the deadliest drug abuse epidemic in U.S. history. China is also emerging as a laundering hub for drug money, according to a U.S. Justice Department indictment unsealed in 2015.

"Intelligence and investigative information have shown that Guangzhou has strong ties to international drug trafficking organizations operating in China and elsewhere," Russell Baer, a DEA special agent in Washington, said in an email. "These criminal groups in Guangzhou utilize trade-based money laundering schemes to legitimize drug profits, use the port facilities as a transit point to ship illegal narcotics, and purchase synthetic drugs along with precursor chemicals."

Chinese officials dispute claims that China is the main source of fentanyl and precursors, noting that the U.S. has produced little supporting data. Nonetheless, Beijing has taken significant steps to crack down on the production and export of synthetic drugs, even though these substances are not widely abused within China. China already controls fentanyl, a painkiller up to 50 times more potent than heroin, along with 18 related compounds and is considering blacklisting four more.

U.S. officials have been pressing China to control additional opioids, which can be easily purchased online from vendors in China. China, meanwhile, has been seeking U.S. support to place ketamine, an anesthetic widely abused in China, on a U.N.-maintained list of internationally controlled substances.

"We believe Mr. Rosenberg's visit will improve both sides' understanding and trust. It will help to improve cooperation in cracking down on drug crimes," China's National Narcotics Control Commission told AP, noting that Hu Minglang, then Director General of China's Narcotics Control Bureau, already visited Washington in September.

Associated Press researcher Fu Ting in Shanghai contributed to this report.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page
2Share
Asia
The U.S. Drug Enforcement Administration is opening a new office in southern China and sending its top administrator to visit next week for the first time in more than a decade, signs of growing U.S. concern about China's role in the global drug trade.The DEA said acting...
AS,China,DEA Visit
416
2017-55-06
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved